NCT04722055View on ClinicalTrials.gov

A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China

CompletedOBSERVATIONAL

Enrollment

1,273

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

January 19, 2022

Study Completion Date

August 8, 2022

Conditions

Colorectal CancerAdvanced AdenocarcinomaHyperplastic PolypColorectal NeoplasmsDigestive System NeoplasmNeoplasms

Interventions

DIAGNOSTIC_TEST

Multigene Methylation Detection Kit

Eligible participants are required to take stool samples for multigene methylation detection and gene sequencing, undergo colonoscopy examination, and have a biopsy when necessary (gold standard).

Trial Locations (1)

Unknown

Shandong Cancer Hospital and Institute, Jinan

All Listed Sponsors

lead

Creative Biosciences (Guangzhou) Co., Ltd.

INDUSTRY

NCT04722055 - A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China | Biotech Hunter | Biotech Hunter